Assembly Biosciences (ASMB) PT Lowered to $15 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mailGet Alerts ASMB Hot Sheet
Price: $19.87 --0%
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Truist Securities analyst Nicole Germino lowered the price target on Assembly Biosciences (NASDAQ: ASMB) to $15.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Assembly Biosciences (ASMB) PT Lowered to $48 at UBS
- GlobalFoundries Inc. (GFS) PT Lowered to $43 at UBS
- trivago N.V. (TRVG) PT Lowered to $4.60 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
